Site Search

Share

X

Search Results

Expand Access to Biomarker Testing in Michigan

... testing will enable more patients to access the most effective treatments for their disease and can potentially help achieve the triple aim of health care: better health outcomes, improved quality of life and reduced costs.  This legislation will ensure Iowans covered by Medicaid and state regulated ...

Medi-Cal Promise Campaign FAQ

... campaign? The biggest determining factor whether someone lives or dies from the disease after a cancer diagnosis is whether or not they have health insurance.  In fact, studies have shown that after a cancer diagnosis, those without insurance are 60 percent more likely to die from the ... candidates who either already voted or will vote on proposals detrimental to Medi-Cal to let Californians know where they stand on protecting health coverage for our most vulnerable.    What is Medi-Cal and how many Californians relay on it? Medi-Cal is a critical component of our health care system as it provides coverage for low-income Californians most in need including children, pregnant women, seniors, people with disabilities ...

Expand Access to Biomarker Testing in Ohio

... and partners are working together to make sure more Ohioans can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing disparities in health outcomes by race, ethnicity, income, and geography. Insurance coverage for biomarker testing is failing to keep pace with innovations and ...

Debra R. Nevels, MSHCM

... from lung cancer. A graduate of the University of Wisconsin-Milwaukee, she gained her Bachelors in African American History and a Master’s in health care management.  Debra currently works with the Medical College of Wisconsin as the Program Manager for Community Outreach and Engagement for the Medical College of Wisconsin Cancer Center. Prior to coming to MCW, Debra worked as Manager for Health Systems – Hospitals Wisconsin for the American Cancer Society (7 years). She is also currently Adjunct Faculty at Concordia University in ...

Expand Access to Biomarker Testing in Massachusetts

... and S.809 to guarantee coverage of evidence-based biomarker testing, so that every patient has a fair shot at the most effective, personalized care. Video of jung_as_biomarker_story   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment ...   What are H. 4339 and S. 809, and why should Massachusetts pass them? H. 4339 and S. 809 would require MassHealth and state-regulated health insurance plans to cover biomarker testing when it is supported by strong clinical evidence and guidelines. As a global leader in life sciences and cancer research, Massachusetts has an opportunity to improve patient outcomes, advance health equity, and ensure that residents of the Commonwealth have access to the most effective, personalized medical care available. This is how we ...

Alliance for a Healthy Montana - Biannual Community Legislative Forums

Join your legislative colleagues   for a conversation with grassroots organizations on health care policies. Light meal served.  Yes. Healthy Communities Matter.       The Alliance for a Healthy Montana is a coalition of healthcare ... providers, patient advocacy groups and voluntaryhealth and tobacco use prevention organizations and otherwho are dedicated t o helping shape a health Montana through specific public policy initiatives.     To RSVP for a forum, simply select from the options below. Tuesday, December  3 ...

Access to Biomarker Testing in Tennessee

... important testing. Video of biomarker_testing_unlocking_personalized_treatments_to_improve_patient_outcomes What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ... to biomarker testing in Tennessee! Have you received biomarker testing? Share your story with us here! Resources: Fact Sheet Biomarkers and Health Equity Types of Biomarker Testing Biomarker Testing Costs and Savings Non-Oncology Biomarker Testing Patient Profiles National Coalition ...

Thank you for calling your member of Congress!

2019 West Virginia Legislative Priorities

... of the American Cancer Society.  ACS CAN supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem for all West Virginians. The following highlights ACS CAN WV 2019 legislative priorities: Reduce the burden of tobacco on West ... quit smoking and educate children to never start. Protect the right to breath smoke-free indoor air; help our communities save lives and improve health with comprehensive smoke-free workplaces We are working with local communities across West Virginia to make restaurants, bars and all ... is an effective solution to help reduce the toll tobacco takes on the health of citizens and the health of our economy through state health care expenditures. Help West Virginians quit tobacco use with barrier-free insurance coverage for tobacco cessation Our health care providers know ...

New Hampshire Virtual Cancer Action Week

... HB 1290, legislation that will study innovative biomarker testing for cancer patients? Biomarker testing is increasingly important for cancer care – and for the treatment of other diseases. Biomarker testing is important step for accessing precision medicine including targeted therapies ... non-academic medical centers are less likely to receive biomarker testing. A study like this will bring together leading experts from across the health care continuum and affords legislators and the public to engage in a public forum on a critical need in our state Vote no on SB 314 - ... and share the link to this page.  Materials: 2022 New Hampshire Priorities Biomarker Testing - Advancing Precision Medicine in Cancer Care Health Equity in Biomarker Testing and Targeted Theraphy     New Hampshire Virtual Cancer Action Week ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy